Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News ProPhase Labs Inc. PRPH

ProPhase Labs Inc is a diversified company that offers a range of services including diagnostic testing, genomics testing and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic services segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers and government organizations. The Consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and also provide personal genomics products and services.


Recent & Breaking News (NDAQ:PRPH)

Prophase Labs, Inc. Announces Intention to Commence Tender Offer to Repurchase Up to 1,700,000 Shares of Its Common Stock

GlobeNewswire November 10, 2017

ProPhase Labs, Inc. Announces Final Results of Its Tender Offer

GlobeNewswire September 29, 2017

ProPhase Labs, Inc. Announces Preliminary Results of Its Tender Offer

GlobeNewswire September 26, 2017

ProPhase Labs, Inc. Announces Commencement of Tender Offer to Repurchase Up to 4.0 Million Shares of Its Common Stock at Price of $2.30 Per Share

GlobeNewswire August 25, 2017

ProPhase Labs, Inc. Announces Intention to Commence Tender Offer to Repurchase Up to 4,000,000 Shares of Its Common Stock

GlobeNewswire August 15, 2017

ProPhase Labs Reports Financial Results for the Three Months and Six Months Ended June 30, 2017

GlobeNewswire August 11, 2017

ProPhase Labs Repurchases 1,061,980 Shares of Its Common Stock

Marketwired June 13, 2017

ProPhase Labs Reports Financial Results for the Three Months Ended March 31, 2017

Marketwired May 15, 2017

ProPhase Provides Shareholder Update

Marketwired April 5, 2017

ProPhase Labs, Inc. Completes Sale of Cold-EEZE(R) Business to Mylan

Marketwired March 29, 2017

ProPhase Labs Reports Financial Results for the Year Ended December 31, 2016

Marketwired February 27, 2017

Worst Performing Industries For October 6, 2016

Benzinga.com  October 6, 2016

Worst Performing Industries For July 26, 2016

Benzinga.com  July 26, 2016

Top Performing Industries For June 9, 2016

Benzinga.com  June 9, 2016

ProPhase Labs Reports Financial Results for the Three Months Ended March 31, 2016

Marketwired May 10, 2016

ProPhase Labs (Nasdaq: PRPH) to Ring The Nasdaq Stock Market Closing Bell

GlobeNewswire April 7, 2016

ProPhase Labs Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2015

Marketwired March 29, 2016

ProPhase Labs to Release Fourth Quarter/Year End Results on Tuesday, March 29th

Marketwired March 25, 2016

ProPhase Labs Discusses the Current Cold Season and Announces Launch of New Product Line, TK Supplements

Marketwired January 13, 2016

ProPhase Labs Reports Financial Results for the Three and Nine Months Ended September 30, 2015

Marketwired November 12, 2015